Thankfully, in June 2021, we reported good news. “A drug sold by AstraZeneca and Merck reduced the recurrence of breast cancer in women with an early but aggressive form of the disease.…
Roche Pulls the Plug on Its Breast Cancer Drug
Living Well with Cancer Being Safe, Cancer Research, Medical Profession, Medicine, Ups and Downs breast cancer, failed testing, FDA, Roche, Tecentriq